Ryan Stewart

Ryan Stewart, CPA, has a diverse work experience in finance and accounting positions. Ryan started their career at Cherry Bekaert LLP as a Senior Accountant from January 2013 to September 2015. Following that, they worked at Melinta Therapeutics, first as a Senior Accountant from September 2015 to August 2017, and then as an Accounting Manager from August 2017 to May 2018. At Melinta Therapeutics, they were responsible for financial analysis, budgeting, forecasting, and SEC reporting.

In 2018, Ryan joined Dova Pharmaceuticals as a Manager of Financial Planning & Analysis, where they worked until April 2019. Currently, they hold the position of Senior Director of Financial Planning & Analysis at G1 Therapeutics, Inc. Prior to this role, they served as the Director of Financial Planning & Analysis at G1 Therapeutics from January 2021 to January 2023 and as the Associate Director of Financial Planning & Analysis from April 2019 to January 2021.

Overall, Ryan Stewart demonstrates a solid background in financial planning, analysis, and accounting, with expertise in SEC reporting and budgeting.

Ryan Stewart, CPA holds a Master's degree in Accounting from William & Mary. Prior to this, they obtained a Bachelor of Business Administration (B.B.A.) in Accounting from the same institution. In August 2015, they became a Certified Public Accountant through the AICPA.